Quick Answer
Evolus, Inc. reported Total Revenue of $297.18 million for fiscal year 2025.
Evolus, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $297.18M +11.6% |
$266.27M +31.8% |
$202.09M +36.0% |
$148.62M +49.1% |
$99.67M +76.3% |
$56.54M +61.9% |
| Revenue (ASC 606) | $297.18M +11.6% |
$266.27M +31.8% |
$202.09M +36.0% |
$148.62M +49.1% |
$99.67M +76.3% |
$56.54M +61.9% |
| Net Income | -$51.64M -2.4% |
-$50.42M +18.3% |
-$61.69M +17.1% |
-$74.41M -59.0% |
-$46.81M +71.3% |
-$163.01M -81.1% |
| Diluted EPS | -$0.80 +1.2% |
-$0.81 +25.0% |
-$1.08 +18.8% |
-$1.33 -41.5% |
-$0.94 +80.5% |
-$4.83 |
| Total Assets | $225.87M -2.9% |
$232.57M +23.1% |
$189.00M +6.2% |
$177.98M -30.9% |
$257.48M +23.2% |
$209.07M -13.0% |
| Cash and Equivalents | $53.83M -38.1% |
$86.95M +38.4% |
$62.84M +16.5% |
$53.92M -63.1% |
$146.26M +42.6% |
$102.56M -6.7% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | -$23.11M -518.4% |
$5.52M +126.7% |
-$20.69M -211.8% |
$18.50M -77.4% |
$81.88M +212.2% |
-$72.96M -191.8% |
| R&D Expense | — | — | — | — | $2.06M +19.9% |
$1.72M -56.7% |
| Operating Income | -$32.66M +5.1% |
-$34.41M +30.1% |
-$49.23M +24.6% |
-$65.33M -47.1% |
-$44.41M +71.0% |
-$153.07M -54.7% |
| Gross Profit | $197.11M +8.1% |
$182.30M +32.5% |
$137.57M +53.2% |
$89.77M | — | — |
| Shares Outstanding | 65.01M +2.4% |
63.50M +9.8% |
57.82M +2.8% |
56.26M +1.2% |
55.58M +64.7% |
33.75M +0.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $68.97M | +12.9% | -0.6% |
| Revenue (ASC 606) | September 30, 2025 | $68.97M | +12.9% | -0.6% |
| Net Income | September 30, 2025 | -$15.74M | +17.9% | +8.2% |
| Diluted EPS | September 30, 2025 | -$0.24 | +20.0% | +11.1% |
| Total Assets | September 30, 2025 | $219.00M | -4.6% | -4.3% |
| Cash and Equivalents | September 30, 2025 | $43.52M | -48.8% | -29.5% |
| Long-Term Debt | June 30, 2020 | $74.17M | +1.8% | +0.4% |
| Stockholders Equity | September 30, 2025 | -$28.76M | -588.3% | -54.2% |
| R&D Expense | March 31, 2022 | $468.0K | -44.4% | +55.5% |
| Operating Income | September 30, 2025 | -$11.50M | +25.7% | -12.6% |
| Gross Profit | September 30, 2025 | $45.84M | +8.9% | +1.1% |
| Shares Outstanding | September 30, 2025 | 64.77M | +2.4% | +0.2% |
- Evolus, Inc. reported Total Revenue of $297.18 million for fiscal year 2025.
- Evolus, Inc. showed an increase of +11.6% in Total Revenue compared to the prior fiscal year.
- Evolus, Inc. reported Revenue (ASC 606) of $297.18 million for fiscal year 2025.
- Evolus, Inc. showed an increase of +11.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Evolus, Inc. reported Net Income of -$51.64 million for fiscal year 2025.
- Evolus, Inc. showed a decrease of -2.4% in Net Income compared to the prior fiscal year.
- Evolus, Inc. reported Diluted EPS of $0.80 per share (loss) for fiscal year 2025.
- Evolus, Inc. showed an increase of +1.2% in Diluted EPS compared to the prior fiscal year.
- Evolus, Inc. reported Total Assets of $225.87 million for fiscal year 2025.
- Evolus, Inc. showed a decrease of -2.9% in Total Assets compared to the prior fiscal year.
- Evolus, Inc. reported Cash and Equivalents of $53.83 million for fiscal year 2025.
- Evolus, Inc. showed a decrease of -38.1% in Cash and Equivalents compared to the prior fiscal year.
- Evolus, Inc. reported Long-Term Debt of $73.51 million for fiscal year 2019.
- Evolus, Inc. reported Stockholders Equity of -$23.11 million for fiscal year 2025.
- Evolus, Inc. showed a decrease of -518.4% in Stockholders Equity compared to the prior fiscal year.
- Evolus, Inc. reported R&D Expense of $2.06 million for fiscal year 2021.
- Evolus, Inc. showed an increase of +19.9% in R&D Expense compared to the prior fiscal year.
- Evolus, Inc. reported Operating Income of -$32.66 million for fiscal year 2025.
- Evolus, Inc. showed an increase of +5.1% in Operating Income compared to the prior fiscal year.
- Evolus, Inc. reported Gross Profit of $197.11 million for fiscal year 2025.
- Evolus, Inc. showed an increase of +8.1% in Gross Profit compared to the prior fiscal year.
- Evolus, Inc. reported Shares Outstanding of 65.01 million shares for fiscal year 2025.
- Evolus, Inc. showed an increase of +2.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: